Literature DB >> 29726314

Effect of depression on cognition after mild traumatic brain injury in adults.

Douglas P Terry1,2,3,4, Michelle Brassil1,2, Grant L Iverson1,2,3,4, William J Panenka5,6, Noah D Silverberg1,7,8.   

Abstract

OBJECTIVE: The current study examined the effect of depression on cognitive test performance in a sample of adults seeking treatment for a mild traumatic brain injury (MTBI). We hypothesized that patients with greater depressive symptoms would perform worse on tasks of fluid cognition compared to those without depression, after controlling for potential confounds.
METHOD: Patients (N = 76) completed a brief cognitive test battery (NIH Toolbox Cognition Battery; NIHTB-CB) and a depression screening questionnaire (PHQ-9) at 11.7-weeks post injury (SD = 6.3 range 2-26). Cognitive scores were adjusted for age, education, gender, and race/ethnicity. Depressive symptoms were examined continuously and dichotomized as: (1) total PHQ-9 score of ≥ 10, the optimal cut-off for Major Depressive Disorder caseness from prior research, and (2) five or more symptoms of depression, including either depressed mood or anhedonia (i.e. DSM-5-based definition).
RESULTS: Twenty-seven patients (35.5%) met DSM-5-based criteria for depression and 42 (55.3%) met criteria based on PHQ-9 > 10. Depression symptom severity correlated with lower fluid cognition composite scores [r = -.22, p = .05] and contributed to the prediction of fluid cognition performance in a model that controlled for time since injury and crystallized cognitive abilities [F(3, 72) = 7.49, p < .001; R2 = 20.6%]. Examining specific NIHTB-CB fluid subtests, the largest group differences were seen on processing speed (d = .40-.49), cognitive flexibility (d = .32-.36), and episodic memory (d = .20-.34). Depression severity was strongly associated with overall post-concussion symptom burden (r = .77, p < .001).
CONCLUSION: Depression is a common comorbidity and an important factor to consider when interpreting neurocognitive test performance in adults with concussion in a clinical setting.

Entities:  

Keywords:  MTBI; Mild traumatic brain injury; cognition; depression; neuropsychological functioning

Mesh:

Year:  2018        PMID: 29726314     DOI: 10.1080/13854046.2018.1459853

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  6 in total

1.  Effectiveness of a guideline implementation tool for supporting management of mental health complications after mild traumatic brain injury in primary care: protocol for a randomised controlled trial.

Authors:  Noah D Silverberg; Thalia Otamendi; Penelope Ma Brasher; Jeffrey R Brubacher; Linda C Li; Pierre-Paul Lizotte; William J Panenka; Frank X Scheuermeyer; Patrick Archambault
Journal:  BMJ Open       Date:  2022-06-21       Impact factor: 3.006

2.  Relationship Between Depression and Stress Coping Ability Among Residents in Japan: A Two-Year Longitudinal Study.

Authors:  Makoto Ito; Emiko Seo; Takami Maeno; Ryoko Ogawa; Tetsuhiro Maeno
Journal:  J Clin Med Res       Date:  2018-07-31

Review 3.  Antidepressants for depression after concussion and traumatic brain injury are still best practice.

Authors:  Noah D Silverberg; William J Panenka
Journal:  BMC Psychiatry       Date:  2019-03-27       Impact factor: 3.630

Review 4.  Memory rehabilitation: restorative, specific knowledge acquisition, compensatory, and holistic approaches.

Authors:  Yashoda Gopi; Edward Wilding; Christopher R Madan
Journal:  Cogn Process       Date:  2022-07-05

5.  Cognitive profiles in persons with opioid use disorder enrolled in methadone treatment.

Authors:  Victoria Sanborn; John Gunstad; Roman Shrestha; Colleen B Mistler; Michael M Copenhaver
Journal:  Appl Neuropsychol Adult       Date:  2020-05-28       Impact factor: 2.050

6.  Promoting early treatment for mild traumatic brain injury in primary care with a guideline implementation tool: a pilot cluster randomised trial.

Authors:  Noah D Silverberg; William J Panenka; Pierre-Paul Lizotte; Mark T Bayley; Derry Dance; Linda C Li
Journal:  BMJ Open       Date:  2020-10-20       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.